138 related articles for article (PubMed ID: 6191988)
1. Elucidation of pathways of 5-fluorouracil metabolism in xenografts of human colorectal adenocarcinoma.
Houghton JA; Houghton PJ
Eur J Cancer Clin Oncol; 1983 Jun; 19(6):807-15. PubMed ID: 6191988
[TBL] [Abstract][Full Text] [Related]
2. A comparison of 5-fluorouracil metabolism in human colorectal cancer and colon mucosa.
Peters GJ; van Groeningen CJ; Laurensse EJ; Pinedo HM
Cancer; 1991 Nov; 68(9):1903-9. PubMed ID: 1717130
[TBL] [Abstract][Full Text] [Related]
3. Role of uridine phosphorylase in the anabolism of 5-fluorouracil.
Schwartz PM; Moir RD; Hyde CM; Turek PJ; Handschumacher RE
Biochem Pharmacol; 1985 Oct; 34(19):3585-9. PubMed ID: 2996553
[TBL] [Abstract][Full Text] [Related]
4. Combinations of 5-FU, hypoxanthine and allopurinol in chemotherapy for human colon adenocarcinoma xenografts.
Houghton JA; Houghton PJ
Cancer Treat Rep; 1982 May; 66(5):1201-6. PubMed ID: 7083222
[TBL] [Abstract][Full Text] [Related]
5. The selectivity of action of methotrexate in combination with 5-fluorouracil in xenografts of human colon adenocarcinomas.
Houghton JA; Tice AJ; Houghton PJ
Mol Pharmacol; 1982 Nov; 22(3):771-8. PubMed ID: 7155134
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5'-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes.
Peters GJ; Laurensse E; Leyva A; Lankelma J; Pinedo HM
Cancer Res; 1986 Jan; 46(1):20-8. PubMed ID: 2415245
[TBL] [Abstract][Full Text] [Related]
7. Enzymes of the de novo and salvage pathways for pyrimidine biosynthesis in normal colon, colon carcinoma, and xenografts.
Ahmed NK
Cancer; 1984 Oct; 54(7):1370-3. PubMed ID: 6088027
[TBL] [Abstract][Full Text] [Related]
8. On the mechanism of cytotoxicity of fluorinated pyrimidines in four human colon adenocarcinoma xenografts maintained in immune-deprived mice.
Houghton JA; Houghton PJ
Cancer; 1980 Mar; 45(5 Suppl):1159-67. PubMed ID: 6444543
[TBL] [Abstract][Full Text] [Related]
9. Studies on a pyrimidine phosphoribosyltransferase from murine leukemia P1534J. Partial purification, substrate specificity, and evidence for its existence as a bifunctional complex with orotidine 5-phosphate decarboxylase.
Reyes P; Guganig ME
J Biol Chem; 1975 Jul; 250(13):5097-108. PubMed ID: 1171096
[TBL] [Abstract][Full Text] [Related]
10. The role of divalent magnesium in activating the reaction catalyzed by orotate phosphoribosyltransferase.
Bhatia MB; Grubmeyer C
Arch Biochem Biophys; 1993 Jun; 303(2):321-5. PubMed ID: 7685580
[TBL] [Abstract][Full Text] [Related]
11. Effect of administration of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on the anti-tumor efficacy of 5-fluoro-2'-deoxyuridine against murine colon tumor C26-10.
Ashour OM; Naguib FN; Goudgaon NM; Schinazi RF; el Kouni MH
Biochem Pharmacol; 2000 Sep; 60(5):687-92. PubMed ID: 10927027
[TBL] [Abstract][Full Text] [Related]
12. [Influence on 5-fluorouracil metabolism by combination of interferon-alpha and 5-fluorouracil against human hepatocellular carcinoma xenografts].
Jin CD; Yamamoto T; Nakamura M; Arai I; Kishin R; Xing X; Nagano H; Dono K; Umeshita K; Nakamori S; Sakon M; Monden M
Gan To Kagaku Ryoho; 2004 Oct; 31(10):1511-5. PubMed ID: 15508442
[TBL] [Abstract][Full Text] [Related]
13. The crystal structure of the orotate phosphoribosyltransferase complexed with orotate and alpha-D-5-phosphoribosyl-1-pyrophosphate.
Scapin G; Ozturk DH; Grubmeyer C; Sacchettini JC
Biochemistry; 1995 Aug; 34(34):10744-54. PubMed ID: 7545004
[TBL] [Abstract][Full Text] [Related]
14. Activation pathways of 5-fluorouracil in rat organs and in PC12 cells.
Mascia L; Ipata PL
Biochem Pharmacol; 2001 Jul; 62(2):213-8. PubMed ID: 11389880
[TBL] [Abstract][Full Text] [Related]
15. Modulation of 5-fluorouracil metabolism and cytotoxicity by antimetabolite pretreatment in human colorectal adenocarcinoma HCT-8.
Benz C; Cadman E
Cancer Res; 1981 Mar; 41(3):994-9. PubMed ID: 7459888
[TBL] [Abstract][Full Text] [Related]
16. [Estimation of pathways of 5-fluorouracil anabolism in human cancer cells in vitro and in vivo].
Fukushima M; Nomura H; Murakami Y; Shirasaka T; Aiba K
Gan To Kagaku Ryoho; 1996 May; 23(6):721-31. PubMed ID: 8645024
[TBL] [Abstract][Full Text] [Related]
17. Inhibition by methotrexate of the stable incorporation of 5-fluorouracil into murine bone marrow DNA.
Sawyer RC; Stolfi RL; Martin DS; Balis ME
Biochem Pharmacol; 1989 Jul; 38(14):2305-11. PubMed ID: 2751696
[TBL] [Abstract][Full Text] [Related]
18. Half-of-sites binding of orotidine 5'-phosphate and alpha-D-5-phosphorylribose 1-diphosphate to orotate phosphoribosyltransferase from Saccharomyces cerevisiae supports a novel variant of the Theorell-Chance mechanism with alternating site catalysis.
McClard RW; Holets EA; MacKinnon AL; Witte JF
Biochemistry; 2006 Apr; 45(16):5330-42. PubMed ID: 16618122
[TBL] [Abstract][Full Text] [Related]
19. Comparison of pyrimidine nucleotide synthetic enzymes involved in 5-fluorouracil metabolism between human adenocarcinomas and squamous cell carcinomas.
Maehara Y; Moriguchi S; Emi Y; Watanabe A; Kohnoe S; Tsujitani S; Sugimachi K
Cancer; 1990 Jul; 66(1):156-61. PubMed ID: 2162241
[TBL] [Abstract][Full Text] [Related]
20. Phosphoribosyl pyrophosphate, pool size and tissue levels as a determinant of 5-fluorouracil response in murine colonic adenocarcinomas.
Ardalan B; Villacorte D; Heck D; Corbett T
Biochem Pharmacol; 1982 Jun; 31(11):1989-92. PubMed ID: 6180752
[No Abstract] [Full Text] [Related]
[Next] [New Search]
